Elevated Cardiac Troponin I following Asymptomatic Intradialytic Hypotension: A Pilot Study with a 2-Year Follow-Up
Toktam Alirezaei1, Mir Jafar Jebreil Moosavi1, Rana Irilouzadian2
1Clinical Research Development Unit of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Asymptomatic intradialytic hypotension (IDH) during hemodialysis (HD) is linked to increased cardiac troponin I (cTnI) levels in end-stage renal disease (ESRD) patients. Monitoring blood pressure during HD is crucial for predicting cardiac events.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Intradialytic hypotension (IDH) is a common complication in hemodialysis (HD) for end-stage renal disease (ESRD) patients.
- The impact of asymptomatic IDH on cardiac troponin I (cTnI) levels remains unclear.
Purpose of the Study:
- To investigate the association between asymptomatic IDH and elevated cTnI levels.
- To evaluate the long-term cardiovascular outcomes in ESRD patients undergoing HD.
Main Methods:
- 70 asymptomatic ESRD patients with negative predialysis cTnI were monitored during HD sessions.
- Hemodynamic changes and symptoms were recorded.
- Patients were followed for two years for acute coronary syndrome (ACS) and cardiac death.
Main Results:
- Asymptomatic IDH was identified in 38.6% of patients based on 2007 guidelines.
- A significant correlation was found between asymptomatic IDH and elevated postdialysis cTnI levels (r=0.492, p<0.05).
- Patients with elevated cTnI experienced more ACS and cardiac death during follow-up.
Conclusions:
- Asymptomatic IDH during HD significantly affects cTnI levels in ESRD patients.
- Elevated cTnI, influenced by asymptomatic IDH, predicts adverse cardiovascular outcomes.
- Monitoring blood pressure during HD is critical for managing cardiovascular risk in ESRD patients.
Background:
Intradialytic hypotension (IDH) has been recognized as a serious and frequent complication during hemodialysis (HD) of end-stage renal disease (ESRD) patients, but the effect of asymptomatic IDH on cardiac troponin I (cTnI) levels is not definitively elucidated.
Methods:
70 asymptomatic HD patients with negative predialysis cTnI were included. They were on maintenance HD thrice weekly. All patients were monitored during the HD session for hemodynamic changes and symptoms related to IDH. Patients were followed for two years, and their outcomes are noted as an acute coronary syndrome (ACS), cardiac death, no ACS, noncardiac death, and kidney transplant.
Results:
Compared with the baseline blood pressure values, there was a drop in systolic blood pressure for all subjects, but according to the 2007 European Best Practice Guidelines on hemodynamic instability, asymptomatic IDH was defined in 27 (38.6%) patients. The results demonstrated a significant correlation (r = 0.492) (p < 0.05) between asymptomatic IDH and elevated postdialysis levels of cTnI. In 2-year follow-up of patients, ACS and cardiac death happened more in patients with elevated cTnI.
Conclusion:
The results of our study suggest that asymptomatic IDH affects cTnI levels. Given that cTnI is a marker of myocardial damage and a predictor of cardiovascular mortality in ESRD patients, these findings recommend that considering the asymptomatic decrease in blood pressure levels during HD is very important and critical.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention


